Exactech received clearance from the FDA to market the Optetrak Logic Constrained Condylar Prosthesis.
Here are four observations:
1. The device is intended for use in revision knee arthroplasty cases. It is also indicated for when previous devices have failed.
2. The system aims to achieve optimal implant placement and bone coverage.
3. The Optetrak Logic CC system will have limited availability in 2015 and a full market launch in 2016.
4. Exactech is a medical device company focusing on solutions for hip, knee shoulder and spine surgery.